Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Céline Charrier"'
Autor:
Paul Humbert, Meadhbh Á. Brennan, Julien De Lima, Régis Brion, Annie Adrait, Céline Charrier, Bénédicte Brulin, Valérie Trichet, Yohann Couté, Frédéric Blanchard, Pierre Layrolle
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract In bone regeneration induced by the combination of mesenchymal stromal cells (MSCs) and calcium-phosphate (CaP) materials, osteoclasts emerge as a pivotal cell linking inflammation and bone formation. Favorable outcomes are observed despite
Externí odkaz:
https://doaj.org/article/8c0605303bff4042827151db8a18481c
Autor:
Brice Moukengue, Hannah K Brown, Céline Charrier, Séverine Battaglia, Marc Baud'huin, Thibaut Quillard, Therese M Pham, Ioannis S Pateras, Vassilis G Gorgoulis, Thomas Helleday, Dominique Heymann, Ulrika Warpman Berglund, Benjamin Ory, Francois Lamoureux
Publikováno v:
EBioMedicine, Vol 53, Iss , Pp - (2020)
ABSTRACT: Background: Osteosarcoma (OS) is the most common primary malignant bone tumour. Unfortunately, no new treatments are approved and over the last 30 years the survival rate remains only 30% at 5 years for poor responders justifying an urgent
Externí odkaz:
https://doaj.org/article/4adcf80b973340c5acc405a66af0dad8
Autor:
Louise Marchandet, Morgane Lallier, Céline Charrier, Marc Baud’huin, Benjamin Ory, François Lamoureux
Publikováno v:
Cancers, Vol 13, Iss 4, p 683 (2021)
Osteosarcoma (OS) is the most common primary bone tumor, mainly occurring in children and adolescents. Current standard therapy includes tumor resection associated with multidrug chemotherapy. However, patient survival has not evolved for the past de
Externí odkaz:
https://doaj.org/article/5f4147535f8a439794def08c8089c577
Autor:
Emilien Orgebin, François Lamoureux, Bertrand Isidor, Céline Charrier, Benjamin Ory, Frédéric Lézot, Marc Baud’huin
Publikováno v:
Cells, Vol 9, Iss 9, p 2080 (2020)
Ribosomopathies are a group of rare diseases in which genetic mutations cause defects in either ribosome biogenesis or function, given specific phenotypes. Ribosomal proteins, and multiple other factors that are necessary for ribosome biogenesis (rRN
Externí odkaz:
https://doaj.org/article/06283ce7d2af4ad5a721287cd773d3b6
Autor:
Olivier Espitia, Mathias Chatelais, Marja Steenman, Céline Charrier, Blandine Maurel, Steven Georges, Rémi Houlgatte, Franck Verrecchia, Benjamin Ory, François Lamoureux, Dominique Heymann, Yann Gouëffic, Thibaut Quillard
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191976 (2018)
Vascular calcification is a strong and independent predictive factor for cardiovascular complications and mortality. Our previous work identified important discrepancies in plaque composition and calcification types between carotid and femoral arteri
Externí odkaz:
https://doaj.org/article/058f2ba2176a48dca805908cb2990c69
Autor:
Jean-Michel Davaine, Thibaut Quillard, Régis Brion, Olivier Lapérine, Béatrice Guyomarch, Thierry Merlini, Mathias Chatelais, Florian Guilbaud, Meadhbh Áine Brennan, Céline Charrier, Dominique Heymann, Yann Gouëffic, Marie-Françoise Heymann
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107642 (2014)
Background and purposeVascular calcification, recapitulating bone formation, has a profound impact on plaque stability. The aim of the present study was to determine the influence of bone-like vascular calcification (named osteoid metaplasia = OM) an
Externí odkaz:
https://doaj.org/article/4b4a0f94d79845ea8e36fb623f213069
Autor:
Bérengère Gobin, Gatien Moriceau, Benjamin Ory, Céline Charrier, Régis Brion, Frederic Blanchard, Françoise Redini, Dominique Heymann
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90795 (2014)
Osteosarcoma is the most common primary malignant bone tumour characterized by osteoid production and/or osteolytic lesions of bone. A lack of response to chemotherapeutic treatments shows the importance of exploring new therapeutic methods. Imatinib
Externí odkaz:
https://doaj.org/article/fb2278d0ff004fd8976fdb84803705bf
Autor:
Frédéric Blanchard, Françoise Rédini, Dominique Heymann, Carl D. Richards, Paul Pilet, Séverine Battaglia, Céline Charrier, Kanji Mori, Céline Chipoy, Bénédicte Brounais
Supplementary Figures S1-S3 from Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a91e3e0dd6ffa2ab9b719ccbdceb06
https://doi.org/10.1158/1078-0432.22439440
https://doi.org/10.1158/1078-0432.22439440
Autor:
Frédéric Blanchard, Françoise Rédini, Dominique Heymann, Carl D. Richards, Paul Pilet, Séverine Battaglia, Céline Charrier, Kanji Mori, Céline Chipoy, Bénédicte Brounais
Purpose: In cultures, the cytokine oncostatin M (OSM) reduces the growth and induces differentiation of osteoblasts and osteosarcoma cells into glial/osteocytic cells. Moreover, OSM sensitizes these cells to apoptosis driven by various death inducers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c216e17bc5de7954ac803ec5ad7c807
https://doi.org/10.1158/1078-0432.c.6516910.v1
https://doi.org/10.1158/1078-0432.c.6516910.v1
Autor:
Dominique Heymann, Françoise Rédini, Jukka Mönkkönen, Leonard D. Shultz, Marc G. Denis, Paul Pilet, Séverine Battaglia, Céline Charrier, Régis Brion, Frédéric Blanchard, Chiara Riganti, Laura Mitrofan, Benjamin Ory, Gatien Moriceau
Despite recent improvements in therapeutic management of osteosarcoma, ongoing challenges in improving the response to chemotherapy warrants new strategies still needed to improve overall patient survival. In this study, we investigated in vivo the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb1c7faae988b3aca2fd32323ab46ba4
https://doi.org/10.1158/0008-5472.c.6500808
https://doi.org/10.1158/0008-5472.c.6500808